GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » ROC (Joel Greenblatt) %

3SBio, (FRA:YFK) ROC (Joel Greenblatt) % : 41.40% (As of Dec. 2016)


View and export this data going back to . Start your Free Trial

What is 3SBio, ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. 3SBio,'s annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2016 was 41.40%.

The historical rank and industry rank for 3SBio,'s ROC (Joel Greenblatt) % or its related term are showing as below:

FRA:YFK' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 29.19   Med: 44.11   Max: 94.53
Current: 45.4

During the past 13 years, 3SBio,'s highest ROC (Joel Greenblatt) % was 94.53%. The lowest was 29.19%. And the median was 44.11%.

FRA:YFK's ROC (Joel Greenblatt) % is not ranked
in the Biotechnology industry.
Industry Median: -332.005 vs FRA:YFK: 45.40

3SBio,'s 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 22.90% per year.


3SBio, ROC (Joel Greenblatt) % Historical Data

The historical data trend for 3SBio,'s ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, ROC (Joel Greenblatt) % Chart

3SBio, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec14 Dec15 Dec16
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.23 38.54 111.67 95.30 60.14

3SBio, Semi-Annual Data
Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.26 89.95 64.57 40.48 41.40

Competitive Comparison of 3SBio,'s ROC (Joel Greenblatt) %

For the Biotechnology subindustry, 3SBio,'s ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3SBio,'s ROC (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio,'s ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where 3SBio,'s ROC (Joel Greenblatt) % falls into.



3SBio, ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2016 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 35.168 + 203.864) - (75.817 + 0 + 3.155)
=160.06

Working Capital(Q: Dec. 2016 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(107.618 + 35.954 + 20.599) - (82.218 + 0 + 3.428)
=78.525

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of 3SBio, for the quarter that ended in Dec. 2016 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2016 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2016  Q: Dec. 2016
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=156.378/( ( (275.356 + max(160.06, 0)) + (241.502 + max(78.525, 0)) )/ 2 )
=156.378/( ( 435.416 + 320.027 )/ 2 )
=156.378/377.7215
=41.40 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2016) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3SBio,  (FRA:YFK) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


3SBio, ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of 3SBio,'s ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio, (FRA:YFK) Business Description

Traded in Other Exchanges
N/A
Address
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines